Refine
Has Fulltext
- yes (49)
Is part of the Bibliography
- yes (49)
Year of publication
Document Type
- Journal article (49)
Language
- English (49) (remove)
Keywords
- ischemic stroke (10)
- stroke (8)
- atrial fibrillation (4)
- hypertension (3)
- mortality (3)
- Stroke (2)
- cardiovascular risk factors (2)
- chronic kidney disease (2)
- diabetes mellitus (2)
- epidemiology (2)
Institute
- Institut für Klinische Epidemiologie und Biometrie (45)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (15)
- Medizinische Klinik und Poliklinik I (14)
- Neurologische Klinik und Poliklinik (10)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (6)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (3)
- Frauenklinik und Poliklinik (2)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Psychotherapie und Medizinische Psychologie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
Sonstige beteiligte Institutionen
Background:
The Catechol-O-methyltransferase (COMT) represents the key enzyme in catecholamine degradation. Recent studies suggest that the COMT rs4680 polymorphism is associated with the response to endogenous and exogenous catecholamines. There are, however, conflicting data regarding the COMT Met/Met phenotype being associated with an increased risk of acute kidney injury (AKI) after cardiac surgery. The aim of the current study is to prospectively investigate the impact of the COMT rs4680 polymorphism on the incidence of AKI in patients undergoing cardiac surgery.
Methods:
In this prospective single center cohort study consecutive patients hospitalized for elective cardiac surgery including cardiopulmonary-bypass (CPB) were screened for participation. Demographic clinical data, blood, urine and tissue samples were collected at predefined time points throughout the clinical stay. AKI was defined according to recent recommendations of the Kidney Disease Improving Global Outcome (KDIGO) group. Genetic analysis was performed after patient enrolment was completed.
Results:
Between April and December 2014, 150 patients were recruited. The COMT genotypes were distributed as follows: Val/Met 48.7%, Met/Met 29.3%, Val/Val 21.3%. No significant differences were found for demography, comorbidities, or operative strategy according to the underlying COMT genotype. AKI occurred in 35 patients (23.5%) of the total cohort, and no differences were evident between the COMT genotypes (20.5% Met/Met, 24.7% Val/Met, 25.0% Val/Val, p = 0.66). There were also no differences in the post-operative period, including ICU or in-hospital stay.
Conclusions:
We did not find statistically significant variations in the risk for postoperative AKI, length of ICU or in-hospital stay according to the underlying COMT genotype.